Validated using a knockout cell line
Recombinant
RabMAb

Recombinant Anti-BRG1 antibody [EPNCIR111A] - BSA and Azide free (ab215998)

Publishing research using ab215998? Please let us know so that we can cite the reference in this datasheet.

ab215998 has been referenced in 4 publications.

  • Otte A  et al. In vitro and in vivo therapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model. Orphanet J Rare Dis 9:126 (2014). WB ; Human . PubMed: 25103190
  • Goljanek-Whysall K  et al. myomiR-dependent switching of BAF60 variant incorporation into Brg1 chromatin remodeling complexes during embryo myogenesis. Development 141:3378-87 (2014). WB ; Mouse . PubMed: 25078649
  • Ramos P  et al. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet 46:427-9 (2014). Human . PubMed: 24658001
  • Madsen MS  et al. Peroxisome proliferator-activated receptor ? and C/EBPa synergistically activate key metabolic adipocyte genes by assisted loading. Mol Cell Biol 34:939-54 (2014). ChIP . PubMed: 24379442

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up